Product References
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
EMBO molecular medicine
Zhu L,Retana D,García-Gómez P,Álvaro-Espinosa L,Priego N,Masmudi-Martín M,Yebra N,Miarka L,Hernández-Encinas E,Blanco-Aparicio C,Martínez S,Sobrino C,Ajenjo N,Artiga MJ,Ortega-Paino E,Torres-Ruiz R,Rodríguez-Perales S,Soffietti R,Bertero L,Cassoni P,Weiss T,Muñoz J,Sepúlveda JM,González-León P,Jiménez-Roldán L,Moreno LM,Esteban O,Pérez-Núñez Á,Hernández-Laín A,Toldos O,Ruano Y,Alcázar L,Blasco G,Fernández-Alén J,Caleiras E,Lafarga M,Megías D,Graña-Castro O,Nör C,Taylor MD,Young LS,Varešlija D,Cosgrove N,Couch FJ,Cussó L,Desco M,Mouron S,Quintela-Fandino M,Weller M,Pastor J,Valiente M
Mon Mar 07 00:00:00 EST 2022
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
EMBO molecular medicine
Zhu L,Retana D,García-Gómez P,Álvaro-Espinosa L,Priego N,Masmudi-Martín M,Yebra N,Miarka L,Hernández-Encinas E,Blanco-Aparicio C,Martínez S,Sobrino C,Ajenjo N,Artiga MJ,Ortega-Paino E,Torres-Ruiz R,Rodríguez-Perales S,Soffietti R,Bertero L,Cassoni P,Weiss T,Muñoz J,Sepúlveda JM,González-León P,Jiménez-Roldán L,Moreno LM,Esteban O,Pérez-Núñez Á,Hernández-Laín A,Toldos O,Ruano Y,Alcázar L,Blasco G,Fernández-Alén J,Caleiras E,Lafarga M,Megías D,Graña-Castro O,Nör C,Taylor MD,Young LS,Varešlija D,Cosgrove N,Couch FJ,Cussó L,Desco M,Mouron S,Quintela-Fandino M,Weller M,Pastor J,Valiente M
Mon Mar 07 00:00:00 EST 2022
CRL4AMBRA1 is a master regulator of D-type cyclins.
Nature
Simoneschi D,Rona G,Zhou N,Jeong YT,Jiang S,Milletti G,Arbini AA,O'Sullivan A,Wang AA,Nithikasem S,Keegan S,Siu Y,Cianfanelli V,Maiani E,Nazio F,Cecconi F,Boccalatte F,Fenyö D,Jones DR,Busino L,Pagano M
Thu Apr 01 00:00:00 EDT 2021
Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex.
Nature chemical biology
Bussiere DE,Xie L,Srinivas H,Shu W,Burke A,Be C,Zhao J,Godbole A,King D,Karki RG,Hornak V,Xu F,Cobb J,Carte N,Frank AO,Frommlet A,Graff P,Knapp M,Fazal A,Okram B,Jiang S,Michellys PY,Beckwith R,Voshol H,Wiesmann C,Solomon JM,Paulk J
Wed Jan 01 00:00:00 EST 2020
Cryptochromes-Mediated Inhibition of the CRL4Cop1-Complex Assembly Defines an Evolutionary Conserved Signaling Mechanism.
Current biology : CB
Rizzini L,Levine DC,Perelis M,Bass J,Peek CB,Pagano M
Mon Jun 17 00:00:00 EDT 2019
Cryptochromes-Mediated Inhibition of the CRL4Cop1-Complex Assembly Defines an Evolutionary Conserved Signaling Mechanism.
Current biology : CB
Rizzini L,Levine DC,Perelis M,Bass J,Peek CB,Pagano M
Mon Jun 17 00:00:00 EDT 2019
Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15.
Cell reports
Ting TC,Goralski M,Klein K,Wang B,Kim J,Xie Y,Nijhawan D
Tue Nov 05 00:00:00 EST 2019
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
Science (New York, N.Y.)
Han T,Goralski M,Gaskill N,Capota E,Kim J,Ting TC,Xie Y,Williams NS,Nijhawan D
Fri Apr 28 00:00:00 EDT 2017
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.
Science (New York, N.Y.)
Han T,Goralski M,Gaskill N,Capota E,Kim J,Ting TC,Xie Y,Williams NS,Nijhawan D
Fri Apr 28 00:00:00 EDT 2017